
Kevin M. Johnson
Examiner (ID: 17187)
| Most Active Art Unit | 1793 |
| Art Unit(s) | 1793, 1732 |
| Total Applications | 255 |
| Issued Applications | 85 |
| Pending Applications | 85 |
| Abandoned Applications | 85 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17226999
[patent_doc_number] => 20210353555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => NANOPARTICLES BASED ON OPTIONALLY ALKOXYLATED POLY(ALKYL CYANOACRYLATES) HAVING A DEFINED DEGREE OF POLYMERIZATION
[patent_app_type] => utility
[patent_app_number] => 17/339138
[patent_app_country] => US
[patent_app_date] => 2021-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19613
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17339138
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/339138 | NANOPARTICLES BASED ON OPTIONALLY ALKOXYLATED POLY(ALKYL CYANOACRYLATES) HAVING A DEFINED DEGREE OF POLYMERIZATION | Jun 3, 2021 | Abandoned |
Array
(
[id] => 18495999
[patent_doc_number] => 20230218525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => Solid Self-Nanoemulsifying Drug Delivery System (S-SNEDDS)
[patent_app_type] => utility
[patent_app_number] => 17/999920
[patent_app_country] => US
[patent_app_date] => 2021-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11139
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999920
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/999920 | Solid Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) | May 25, 2021 | Abandoned |
Array
(
[id] => 20534383
[patent_doc_number] => 12551434
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-17
[patent_title] => Zwitterionic polymer particle compositions and related methods
[patent_app_type] => utility
[patent_app_number] => 17/925234
[patent_app_country] => US
[patent_app_date] => 2021-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 48
[patent_no_of_words] => 27514
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17925234
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/925234 | Zwitterionic polymer particle compositions and related methods | May 19, 2021 | Issued |
Array
(
[id] => 20592343
[patent_doc_number] => 12576039
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-17
[patent_title] => Lipid-polymer compositions and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/323052
[patent_app_country] => US
[patent_app_date] => 2021-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 15014
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17323052
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/323052 | Lipid-polymer compositions and methods of use | May 17, 2021 | Issued |
Array
(
[id] => 17242007
[patent_doc_number] => 20210361750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => Anti-Viral Lactoferrin Facemask
[patent_app_type] => utility
[patent_app_number] => 17/322815
[patent_app_country] => US
[patent_app_date] => 2021-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6404
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17322815
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/322815 | Anti-Viral Lactoferrin Facemask | May 16, 2021 | Abandoned |
Array
(
[id] => 17272760
[patent_doc_number] => 20210378958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => Emulsions and extended release formulations including cannabis-derived compounds and related methods
[patent_app_type] => utility
[patent_app_number] => 17/300337
[patent_app_country] => US
[patent_app_date] => 2021-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1102
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17300337
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/300337 | Emulsions and extended release formulations including cannabis-derived compounds and related methods | May 13, 2021 | Abandoned |
Array
(
[id] => 17312741
[patent_doc_number] => 20210401789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => OPHTHALMIC COMPOSITIONS AND METHODS FOR TREATING EYES
[patent_app_type] => utility
[patent_app_number] => 17/317078
[patent_app_country] => US
[patent_app_date] => 2021-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11399
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17317078
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/317078 | OPHTHALMIC COMPOSITIONS AND METHODS FOR TREATING EYES | May 10, 2021 | Abandoned |
Array
(
[id] => 17480478
[patent_doc_number] => 20220087982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/313312
[patent_app_country] => US
[patent_app_date] => 2021-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9855
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17313312
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/313312 | Pharmaceutical composition | May 5, 2021 | Issued |
Array
(
[id] => 18672839
[patent_doc_number] => 20230310284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => DISSOLVABLE HYDROGEN PEROXIDE TEETH WHITENING STRIP OR FILM
[patent_app_type] => utility
[patent_app_number] => 17/922864
[patent_app_country] => US
[patent_app_date] => 2021-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15210
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17922864
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/922864 | DISSOLVABLE HYDROGEN PEROXIDE TEETH WHITENING STRIP OR FILM | May 4, 2021 | Pending |
Array
(
[id] => 17168656
[patent_doc_number] => 20210322326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => HYDROGEL PARTICLE CARRIERS FOR DELIVERY OF THERAPEUTIC/DIAGNOSTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/232336
[patent_app_country] => US
[patent_app_date] => 2021-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5487
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17232336
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/232336 | HYDROGEL PARTICLE CARRIERS FOR DELIVERY OF THERAPEUTIC/DIAGNOSTIC AGENTS | Apr 15, 2021 | Abandoned |
Array
(
[id] => 17050667
[patent_doc_number] => 20210260101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => POTENTIATED ANTIBIOTIC COMPOSITIONS AND METHODS OF USE FOR TREATING BACTERIAL INFECTIONS AND BIOFILMS
[patent_app_type] => utility
[patent_app_number] => 17/231854
[patent_app_country] => US
[patent_app_date] => 2021-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32491
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231854
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/231854 | POTENTIATED ANTIBIOTIC COMPOSITIONS AND METHODS OF USE FOR TREATING BACTERIAL INFECTIONS AND BIOFILMS | Apr 14, 2021 | Abandoned |
Array
(
[id] => 17154758
[patent_doc_number] => 20210315809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => ORAL CARE COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/227978
[patent_app_country] => US
[patent_app_date] => 2021-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12347
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -47
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17227978
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/227978 | ORAL CARE COMPOSITIONS AND METHODS | Apr 11, 2021 | Abandoned |
Array
(
[id] => 16977563
[patent_doc_number] => 20210221800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => CRYSTALLINE COMPOUNDS AND METHODS OF MAKING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/220245
[patent_app_country] => US
[patent_app_date] => 2021-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50753
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17220245
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/220245 | CRYSTALLINE COMPOUNDS AND METHODS OF MAKING THE SAME | Mar 31, 2021 | Abandoned |
Array
(
[id] => 17472144
[patent_doc_number] => 20220079648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => METHODS OF ALLEVIATING SYMPTOMS OF OCULAR SURFACE DISCOMFORT USING MEDICAL ICE SLURRY
[patent_app_type] => utility
[patent_app_number] => 17/439749
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9593
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17439749
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/439749 | Methods of alleviating symptoms of ocular surface discomfort using medical ice slurry | Mar 25, 2021 | Issued |
Array
(
[id] => 18374246
[patent_doc_number] => 20230149323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => INHIBITORS OF THE INTERACTION OF THE UPAR/FPRS RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 17/916285
[patent_app_country] => US
[patent_app_date] => 2021-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4971
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916285
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/916285 | INHIBITORS OF THE INTERACTION OF THE UPAR/FPRS RECEPTORS | Mar 22, 2021 | Pending |
Array
(
[id] => 17212975
[patent_doc_number] => 20210346311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => Base Composition for Tape Agent
[patent_app_type] => utility
[patent_app_number] => 17/206781
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14076
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17206781
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/206781 | Base Composition for Tape Agent | Mar 18, 2021 | Abandoned |
Array
(
[id] => 18690882
[patent_doc_number] => 20230321044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => TREATMENT OR PREVENTION METHOD FOR CHRONIC HEART FAILURE
[patent_app_type] => utility
[patent_app_number] => 17/796606
[patent_app_country] => US
[patent_app_date] => 2021-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8185
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17796606
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/796606 | TREATMENT OR PREVENTION METHOD FOR CHRONIC HEART FAILURE | Mar 17, 2021 | Pending |
Array
(
[id] => 17095383
[patent_doc_number] => 20210283174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => OXYGENATED EMULSION FOR TREATMENT OF OCULAR INJURY
[patent_app_type] => utility
[patent_app_number] => 17/200253
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9564
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17200253
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/200253 | OXYGENATED EMULSION FOR TREATMENT OF OCULAR INJURY | Mar 11, 2021 | Pending |
Array
(
[id] => 18558148
[patent_doc_number] => 11723366
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-15
[patent_title] => Alkali metal salt for use in treatment of
[patent_app_type] => utility
[patent_app_number] => 17/199917
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 8484
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17199917
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/199917 | Alkali metal salt for use in treatment of | Mar 11, 2021 | Issued |
Array
(
[id] => 16913963
[patent_doc_number] => 20210187055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => LISINOPRIL FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/194021
[patent_app_country] => US
[patent_app_date] => 2021-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19117
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194021
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/194021 | Lisinopril formulations | Mar 4, 2021 | Issued |